The Food and Drug Administration has granted approval to AliveCor for its smartphone-based atrial fibrillation detection algorithm.
The company says the algorithm instantly detects if patients are experiencing AFib through real-time electrocardiogram recordings taken on a mobile phone-based AliveCor Heart Monitor, so physicians can intervene before potentially life-threatening conditions, like strokes, occur. Through AliveCors ECG analysis service, patients can confirm their results with a U.S. board-certified cardiologist or a personal physician.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access